Bluue

Bluue Co. builds artificial intelligence models and data-collection hardware devices for cardiology and maternity care. Its stated mission is to develop frontier models and measurement devices that make high-quality cardiac and maternal care available irrespective of a patient's location or wealth. The company describes itself as founded by researchers from Stanford, Oxford and Berkeley.

The company frames its engineering priorities around four principles: model stability (predictable, computationally transparent behavior that replicates across variations in data and methodology), robustness to messy real-world physiological signals (artifact rejection, edge cases, and the lab-to-field gap, with diverse study volunteers so models perform across skin color, age, gender, body type and ethnicity), interpretability so clinicians can trace model reasoning back to first principles rather than treating outputs as a black box, and accessibility, with tools designed to function where medical infrastructure is limited.

A third-party company directory lists Bluue as a small hardware-and-software company in the biotechnology and health care sectors focused on heart and lung care, offering a mathematical approach to cardiovascular medicine, with Dave Deriso as chief executive.

Business model

Bluue develops both AI models and the physiological data-collection hardware that feeds them, positioning its tools for use in clinical and low-infrastructure settings with a physician kept in the loop. Distribution is described as running through partnerships with NGOs serving remote communities and with research institutions.